Cargando…
SP600125 has a remarkable anticancer potential against undifferentiated thyroid cancer through selective action on ROCK and p53 pathways
Thyroid cancer is the most common endocrine malignancy with increasing incidence worldwide. The majority of thyroid cancer cases are well differentiated with favorable outcome. However, undifferentiated thyroid cancers are one of the most lethal human malignancies because of their invasiveness, meta...
Autores principales: | Grassi, Elisa Stellaria, Vezzoli, Valeria, Negri, Irene, Lábadi, Árpád, Fugazzola, Laura, Vitale, Giovanni, Persani, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742184/ https://www.ncbi.nlm.nih.gov/pubmed/26415230 |
Ejemplares similares
-
Selective killing of p53-deficient cancer cells by SP600125
por: Jemaà, Mohamed, et al.
Publicado: (2012) -
Multicellular spheroids from normal and neoplastic thyroid tissues as a suitable model to test the effects of multikinase inhibitors
por: Cirello, Valentina, et al.
Publicado: (2016) -
Thyroid Cancer Stem-Like Cells: From Microenvironmental Niches to Therapeutic Strategies
por: Grassi, Elisa Stellaria, et al.
Publicado: (2021) -
SP600125 Induces Src and Type I IGF Receptor Phosphorylation Independent of JNK
por: Kong, Qingbin, et al.
Publicado: (2014) -
Characteristics of SP600125 Induced Tetraploid Cells in Comparison With Diploid and Tetraploid Cells of Fish
por: Fan, Yunpeng, et al.
Publicado: (2021)